Sponsor:
National Institutes of Health
UI Contact:
Updated Date:
Nov 10, 2023
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices and funding opportunities:
General Notices
- Notice of NCCIH Technical Assistance Webinar for PAR-23-256 "Feasibility Trials of the NIH Music-based Interventions (MBIs) Toolkit for Brain Disorders of Aging (R34 Clinical Trial Required)"
(NOT-AT-24-024)
National Center for Complementary and Integrative Health
National Institute on Aging
- Notice of NCCIH Technical Assistance Webinar for RFA-AT-24-006 "Resource Center for Cannabis and Cannabinoid Research (U24 Clinical Trial Not Allowed)"
(NOT-AT-24-025)
National Center for Complementary and Integrative Health
- Notice of Technical Assistance Webinar and FAQs for RFA-HD-24-007 (Understanding and Mitigating Health Disparities experienced by People with Disabilities caused by Ableism (R01 Clinical Trial Optional))
(NOT-HD-23-034)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Closing February 1, 2024 Application Receipt Date for RFA-OH-23-005 NIOSH Robotics and Intelligent Mining Technology and Workplace Safety Research (U60)
(NOT-OH-24-002)
National Institute for Occupational Safety and Health
- Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science for UM1 CTSA Hub Awards (RC2 Clinical Trials Optional): Notice of Technical Webinar
(NOT-TR-24-002)
National Center for Advancing Translational Sciences
- Notice of Request for Information (RFI) to Facilitate Cancer Systems immunology Research
(NOT-CA-24-003)
National Cancer Institute
Notice of Changes to Funding Opportunities
- Notice of Change to Integrated Preclinical/Clinical AIDS Vaccine Development Program (IPCAVD) (U19 Clinical Trial Not Allowed), PAR-23-033
(NOT-AI-24-004)
National Institute of Allergy and Infectious Diseases
- Notice of Change to Award Budget for PAR-23-032, Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases from Academic/Non-profit Lab to Marketplace (SBIR [R43/R44] Clinical Trial Not Allowed
(NOT-AR-23-021)
National Institute of Arthritis and Musculoskeletal and Skin Diseases
- Notice of Change to Letter of Intent Due Date for RFA-DK-23-004: Human Islet Research Network - Consortium on Modeling Autoimmune Diabetes (HIRN-CMAD) (UG3/UH3 Clinical Trial Not Allowed)
(NOT-DK-24-002)
National Institute of Diabetes and Digestive and Kidney Diseases
- Notice of Extension of the First Receipt Date of RFA-HG-23-018: Investigator-Initiated Research in Genomics and Health Equity (R21 Clinical Trial (Clinical Trial Optional)
(NOT-HG-24-008)
National Human Genome Research Institute
- Notice of NINRs Scientific Interests for PAR-23-137, NIH Science Education Partnership Award (SEPA) (R25 - Clinical Trial Not Allowed)
(NOT-NR-24-002)
National Institute of Nursing Research
- Notice of Termination of PAR-21-340 "Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science for UM1 CTSA Hub Awards (RC2 Clinical Trial Not Allowed)
(NOT-TR-24-001)
National Center for Advancing Translational Sciences
Notices of Intent to Publish
- Notice of Intent to Publish a Funding Opportunity Announcement for Model Continuums of Care Initiative (MCCI) to Advance Health Equity Among Women and Girls in Racial/Ethnic Minority and Other Marginalized Communities (U34 Clinical Trials Required)
(NOT-AA-24-002)
National Institute on Alcohol Abuse and Alcoholism
- Notice of Intent to Publish a Funding Opportunity Announcement for BRAIN Initiative: Preclinical Proof of Concept for Novel Recording and Modulation Technologies in the Human CNS (R18 - Clinical Trial Not Allowed)
(NOT-NS-24-017)
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Mental Health
Notices of Special Interest
- Notice of Special Interest (NOSI): Development of Organotypic Culture Models for Transplantation Immunology Research
(NOT-AI-23-064)
National Institute of Allergy and Infectious Diseases
- Notice of Special Interest (NOSI): National Cancer Institute Entrepreneurial Education Programs to Facilitate Commercialization of Cancer Relevant Technologies
(NOT-CA-24-001)
National Cancer Institute
- Notice of Special Interest (NOSI): Interventions to promote mental well-being in populations that experience health disparities through social, cultural, and environmental connectedness
(NOT-OD-23-194)
Office of Disease Prevention
National Center for Complementary and Integrative Health
National Institute on Aging
National Institute of Biomedical Imaging and Bioengineering
National Institute of Dental and Craniofacial Research
National Institute of Mental Health
National Institute on Minority Health and Health Disparities
Office of AIDS Research
Office of Research on Women's Health
Funding Opportunities
- NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Not Allowed)
(PAR-23-286)
National Cancer Institute - NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Required)
(PAR-23-287)
National Cancer Institute - NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Basic Experimental Studies with Humans Required)
(PAR-23-288)
National Cancer Institute - Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required)
(PAR-24-035)
National Institute of Arthritis and Musculoskeletal and Skin Diseases - Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)
(PAR-24-036)
National Institute of Arthritis and Musculoskeletal and Skin Diseases - Multi-sectoral preventive interventions that address social determinants of health in populations that experience health disparities (UG3/UH3, Clinical Trial Required)
(PAR-24-053)
Office of Disease Prevention
National Center for Complementary and Integrative Health
National Cancer Institute
National Heart, Lung, and Blood Institute
National Institute on Alcohol Abuse and Alcoholism
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute on Minority Health and Health Disparities
National Institute of Nursing Research
Office of Dietary Supplements
Office of Research on Women's Health - Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science for UM1 CTSA Hub Awards (RC2 Clinical Trials Optional)
(PAR-24-054)
National Center for Advancing Translational Sciences - Phased Research to Support Substance Use Epidemiology, Prevention, and Services Studies (R61/R33 Clinical Trials Optional)
(PAR-24-062)
National Institute on Drug Abuse
National Institute on Alcohol Abuse and Alcoholism - Rural Community-Centered Drug Misuse Prevention and Harm Reduction Research: Addressing Implementation, Dissemination, and Equity Challenges across the Continuum of Care (R61/R33 Clinical Trial Only)
(RFA-DA-24-036)
National Institute on Drug Abuse
Office of Disease Prevention - National Drug Early Warning System Coordinating Center (U01 Clinical Trial Not Allowed)
(RFA-DA-25-029)
National Institute on Drug Abuse - In Vivo High-Resolution Imaging for Inner Ear Visualization (R01 Clinical Trial optional)
(RFA-DC-24-004)
National Institute on Deafness and Other Communication Disorders - Cooperative Agreement for In Vivo High-Resolution Imaging for Inner Ear Visualization (U01 Clinical Trial Required)
(RFA-DC-24-005)
National Institute on Deafness and Other Communication Disorders - Advancing Genomic Medicine Research (R01 Clinical Trial Optional)
(RFA-HG-23-032)
National Human Genome Research Institute
National Cancer Institute - Advancing Genomic Medicine Research (R21 Clinical Trial Optional)
(RFA-HG-23-033)
National Human Genome Research Institute
National Cancer Institute - Advancing Genomic Medicine Research (R03 Clinical Trial Not Allowed)
(RFA-HG-23-048)
National Human Genome Research Institute - Coordinating Center to Support Multi-Sectoral Preventive Interventions that Address Social Determinants of Health in Populations that Experience Health Disparities (U24, Clinical Trial Not Allowed)
(RFA-OD-24-006)
Office of Disease Prevention
National Institute on Minority Health and Health Disparities
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at dsp@uiowa.edu or 313-335-2123, or email Ann Ricketts or Lynn Hudachek.